Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas J Wouters

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Blood|December 15, 2015
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaBas J Wouters, Ruud Delwel
Blood Cells, Molecules & Diseases|December 22, 2007
Gene expression profiling for improved dissection of acute leukemia: a recently identified immature myeloid/T-lymphoid subgroup as an exampleBas J Wouters, Clara Koss, Ruud Delwel
Blood|August 16, 2008
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBas J Wouters, Bob Löwenberg, Ruud Delwel
Blood|January 28, 2009
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcomeBas J Wouters, Bob Löwenberg, Claudia A J Erpelinck-Verschueren, et al.
BMC Bioinformatics|May 25, 2010
HAT: hypergeometric analysis of tiling-arrays with application to promoter-GeneChip dataErdogan Taskesen, Renee Beekman, Jeroen de Ridder, et al.
BMC Bioinformatics|January 20, 2007
Text-derived concept profiles support assessment of DNA microarray data for acute myeloid leukemia and for androgen receptor stimulationRob Jelier, Guido Jenster, Lambert C J Dorssers, et al.
Cancer Research|June 19, 2004
A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancerBalazs Halmos, Daniela S Bassères, Stefano Monti, et al.
Haematologica|October 8, 2008
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingRoel G W Verhaak, Bas J Wouters, Claudia A J Erpelinck, et al.
Blood|May 21, 2011
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markersVeronika Rockova, Saman Abbas, Bas J Wouters, et al.
Blood|August 12, 2009
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation statusFernando P G Silva, Sigrid M A Swagemakers, Claudia Erpelinck-Verschueren, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Blood|December 15, 2015
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaBas J Wouters, Ruud Delwel
Blood Cells, Molecules & Diseases|December 22, 2007
Gene expression profiling for improved dissection of acute leukemia: a recently identified immature myeloid/T-lymphoid subgroup as an exampleBas J Wouters, Clara Koss, Ruud Delwel
Blood|August 16, 2008
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBas J Wouters, Bob Löwenberg, Ruud Delwel
Blood|January 28, 2009
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcomeBas J Wouters, Bob Löwenberg, Claudia A J Erpelinck-Verschueren, et al.
BMC Bioinformatics|May 25, 2010
HAT: hypergeometric analysis of tiling-arrays with application to promoter-GeneChip dataErdogan Taskesen, Renee Beekman, Jeroen de Ridder, et al.
BMC Bioinformatics|January 20, 2007
Text-derived concept profiles support assessment of DNA microarray data for acute myeloid leukemia and for androgen receptor stimulationRob Jelier, Guido Jenster, Lambert C J Dorssers, et al.
Cancer Research|June 19, 2004
A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancerBalazs Halmos, Daniela S Bassères, Stefano Monti, et al.
Haematologica|October 8, 2008
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingRoel G W Verhaak, Bas J Wouters, Claudia A J Erpelinck, et al.
Blood|May 21, 2011
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markersVeronika Rockova, Saman Abbas, Bas J Wouters, et al.
Blood|August 12, 2009
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation statusFernando P G Silva, Sigrid M A Swagemakers, Claudia Erpelinck-Verschueren, et al.
Pageof 3